Evaluation of plaque luminance change by using optical coherence tomography and intracoronary administration of microbubble contrast agent

Evaluation of plaque luminance change by using optical coherence tomography and intracoronary administration of microbubble contrast agent - Evaluation of plaque luminance change by using optical coherence tomography and intracoronary administration of microbubble contrast agent

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015635

Enrollment

Registered

2014-11-10

Start date

2013-10-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease after stent implantation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who plan to have follow-up coronary angiography after stent implantation

Exclusion criteria

Exclusion criteria: Patients who are allergic to contrast Sonazoid or egg, who are pregnant or suspected of pregnancy, who have kidney dysfunction, or patients whom doctor considers inappropriate

Design outcomes

Primary

Measure	Time frame
plaque progression and luminance, neovascularization after stent implantation	—

Countries

Japan

Contacts

Public ContactNorikiyo Oka

Chiba University graduate school of medicine Department of Cardiovascular Medicine

norikiyo.oka@ma.point.ne.jp043-222-7171

Outcome results